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Background: Validation of administrative data is important to assess potential sources of bias in outcome
evaluation and to prevent dissemination of misleading or inaccurate information. The purpose of the study was to
determine the completeness and accuracy of endoscopy data in several administrative data sources in the year
prior to colorectal cancer diagnosis as part of a larger project focused on evaluating the quality of pre-diagnostic
care.
Methods: Primary and secondary data sources for endoscopy were collected from the Alberta Cancer Registry,
cancer medical charts and three different administrative data sources. 1672 randomly sampled patients diagnosed
with invasive colorectal cancer in years 2000–2005 in Alberta, Canada were included. A retrospective validation
study of administrative data for endoscopy in the year prior to colorectal cancer diagnosis was conducted. A gold
standard dataset was created by combining all the datasets. Number and percent identified, agreement and
percent unique to a given data source were calculated and compared across each dataset and to the gold
standard with respect to identifying all patients who underwent endoscopy and all endoscopies received by those
patients.
Results: The combined administrative data and physician billing data identified as high or higher percentage of
patients who had one or more endoscopy (84% and 78%, respectively) and total endoscopy procedures (89% and
81%, respectively) than the chart review (78% for both).
Conclusions: Endoscopy data has a high level of completeness and accuracy in physician billing data alone.
Combined with hospital in/outpatient data it is more complete than chart review alone.
Keywords: Colorectal endoscopy, Data validation, Administrative data, AgreementBackground
Databases that are developed and maintained for adminis-
trative purposes are frequently used in population health
research and disease surveillance because of their avail-
ability, generality, cost-effectiveness and large population
encompassed. The quality of administrative data, however,
is often questioned when the data are employed in health
outcomes research or quality measurement [1-9]. It is,* Correspondence: marcy.winget@albertahealthservices.ca
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reproduction in any medium, provided the ortherefore, important to validate administrative data in
order to assess potential sources of bias in outcome evalu-
ation and to prevent dissemination of misleading or in-
accurate information [10].
Validation studies of administrative data have primarily
focused on diagnosis of disease [10-20]. In cancer re-
search, however, the primary data source used for identi-
fying cancer cases is typically a well-established cancer
registry; administrative data are not usually used or
needed to identify cancer cases. Administrative data,
however, can be very valuable in identifying key proce-
dures received during a cancer patient’s care trajectory
in order to evaluate the care received [21,22], to under-
stand patterns of service delivery [23], and/or to predicthis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ministrative data sources to be used in such studies
should be a critical component of the study itself.
The purpose of the study was to validate the complete-
ness and accuracy of endoscopy data in several adminis-
trative data sources in the year prior to colorectal cancer
diagnosis as part of a larger project focused on evaluat-
ing the quality of the pre-diagnostic care trajectory of
colorectal cancer patients with respect to tests received
and timing of them.
Methods
Inclusion criteria
An approximate 20% random sample of all residents of
Alberta, Canada diagnosed with invasive colon cancer
(International Classification of Diseases for Oncology
(ICD-O) [25] codes: c18, excluding appendix) or rectal
cancer (ICD-O c19 and c20) in years 2000 to 2005,
stratified by stage and year of diagnosis, were identified
from the Alberta Cancer Registry and included in the
study. Patients were excluded for the following reasons:
stage 0 cancer; histology that are not staged according to
the Collaborative Staging Guidelines [26]; or missing the
unique lifetime identifier (ULI). The ULI is a unique
number assigned to all members of the Alberta Health
Care Insurance Program (AHCIP), the publicly-funded
provincial healthcare insurance plan in Alberta. The ULI
is, therefore, used as the anonymized patient identifier in
all provincial administrative databases in Alberta and
was used to link data across data sources for the study.
Chart review data
A chart review using the cancer clinic medical chart was
conducted to identify dates of endoscopy prior to and
including the date of diagnosis. Cancer medical charts
are initially created for all patients diagnosed with cancer
by the Alberta Cancer Registry for use in coding cases.
They include procedure reports such as those for path-
ology, surgery, or endoscopy, plus referral letters and
dictation notes, if the patient is seen by an oncologist;
thus a cancer chart exists for every patient diagnosed
with cancer in the province. The following data were
abstracted from the charts: date and type of endoscopy;
result (cancer, suspicious, not cancer); and source of in-
formation (letter, dictation notes, report).
Administrative health databases
Endoscopy data were obtained from three provincial ad-
ministrative databases, the first two of which conform to
national reporting standards: 1) the Discharge Abstract
Database (hospital inpatient data) which records informa-
tion on all admissions to hospitals in Alberta; 2) the Am-
bulatory Care Classification System Database (hospital
outpatient data), which contains information on alloutpatient visits that occurred in hospitals, such as visits
to hospital-based physicians’ offices, hospital endoscopy
units, and emergency departments; and 3) the Physician
Billing database, which contains all billing claims submit-
ted by physicians remunerated on a fee-for-service basis
and “shadow” billing submitted by physicians employed
through the Alternate Relationship Plan (ARP). The latter
group of physicians comprises a small number of physi-
cians in one city during the time period of this study.
From each data source, dates and codes for endoscopy
procedures were identified that occurred within one year
prior to colorectal cancer diagnosis for each patient
included in the study. The timeframe of one year prior to
diagnosis was determined based on a sensitivity analysis
we conducted comparing endoscopies found 12, 18, or
24 months prior to colorectal cancer diagnosis; roughly
the same number were found regardless of the time frame,
therefore we used one year as the cutoff.
Each data source uses a different coding system and
coding systems changed from ICD-9 to ICD-10 in April
2002 for the hospital datasets. In order to identify endos-
copy codes from each data source appropriately, a litera-
ture review was conducted and input from local
physicians was obtained. Since our purpose was to identify
all lower gastrointestinal endoscopies regardless of pur-
pose, all codes that indicated use of an endoscope were
included. The endoscopy procedure codes included in the
study from each data source are listed in Additional file 1.
Combined administrative dataset
The three administrative datasets were combined using
the assumption that if an endoscopy was identified in
any source then it was assumed to have occurred. This
is because: 1) we expect that most patients will have had
an endoscopy prior to colorectal cancer diagnosis and 2)
it is unlikely that an endoscopy would be identified in
any of the data sources if it was not actually performed;
that is, the probability of a false positive is low. The data
were combined in such a way as to minimize error in
identifying unique endoscopies and also to assess accur-
acy with respect to the date of the endoscopy in the vari-
ous data sources. In practice, it would be reasonable for
an endoscopy code for the same event to appear in a
hospital inpatient record and physician billing record or
hospital outpatient record and physician billing record.
Coding rules and practices should prevent the same
event from being coded in both hospital inpatient and
outpatient data unless an error is made. This is because
procedures that happen to patients as outpatients should
not be entered as a procedure as an inpatient (and vice
versa), even if the patient is admitted the same day.
Similarly, it is unlikely that a patient would undergo
more than one endoscopy on the same day. Further-
more, dates for events in the hospital databases are
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and coded by trained health records technicians. Phys-
ician billing, however, is more prone to error with re-
spect to both the accuracy of the code and the date. In
order to minimize the chance of counting a given endos-
copy more than once and minimize the chance of count-
ing two or more events as one when combining the
datasets, the following rules were applied: 1) if an endos-
copy appeared in both the inpatient and outpatient data-
sets for the same individual and date it was considered
to be the same endoscopy; 2) if an endoscopy in the
physician billing data was within three days of an endos-
copy in either hospital dataset then it was counted as
the same endoscopy. These rules were tested against
rules using three and seven day windows, respectively,
with the result that there was minimal difference in the
number of unique endoscopies identified. If a patient did
not appear in a dataset then the patient was assigned to
the “No Endoscopy” category for that particular dataset.
Gold standard
The gold standard dataset was created by combining all
administrative datasets and the chart review data. If a pro-
cedure was identified in any data set, it was considered to
have occurred in the gold standard. The cancer clinic
medical chart was not adopted as the gold standard be-
cause, even though information that is collected by the
cancer registry to code and stage patients is in these
charts, it is possible that an endoscopy that did not result
in removal of tissue would be missed. Furthermore, al-
though pathology reports are obtained when possible,
some information may be obtained from referral letters or
dictation notes which are subject to error. For this reason
a gold standard was created to maximize the probability of
identifying all unique endoscopies conducted in the year
prior to colorectal cancer diagnosis. The same rules and
assumptions that were followed to create the combined
administrative dataset were applied in creating the gold
standard: 1) if an endoscopy appeared in either data
source then it was assumed to have occurred (probability
of false-positive is low) and 2) endoscopies in the chart re-
view dataset that were within three days of the date of an
endoscopy in the combined administrative dataset were
counted as the same endoscopy.
Data analysis
The measures to evaluate the completeness of the data
were calculated at two levels: 1) comparing the total
number of patients that underwent endoscopy and 2)
comparing the total number of endoscopy procedures
identified in each data source. The following descriptive
statistics were calculated regarding patients who
received an endoscopy and endoscopies identified from
each dataset using the respective totals identified in thegold standard as the denominators for percentages: 1)
total number and percent, 2) the number and percent
identified from one and only one data source, by data
source and, 3) the number and percent identified from
one and only one of the administrative data sources, by
administrative data source; note, these may have also
been identified from the chart review. The purpose of
this latter set of statistics is to indicate the extent to
which each administrative data source contributes
uniquely in the absence of a chart review. The percent-
age of endoscopy procedures that had exact date
matches was used to determine the accuracy of the data.
In order to assess the likelihood that endoscopies were
missed, clinical characteristics and health care service
utilization were compared between patients who had an
endoscopy to those who did not. Specifically, patient age
at diagnosis, disease stage, type of first colorectal cancer-
related healthcare visit (pre-diagnostic or not), and time
from diagnosis to death were explored. These were
selected because they were considered to be potentially
relevant reasons individuals may not receive an endos-
copy prior to colorectal cancer diagnosis. Statistical sig-
nificance was defined at the α=0.05 level. All analyses
were performed using statistical software SAS 9.1.3 (SAS
Institute, Cary, NC, USA) or STATA/SE 10.0 (StataCorp
LP, TX, USA).
Results
There were 1672 patients diagnosed with colorectal cancer
in years 2000–2005 who were randomly selected and
included in the study. Table 1 compares the patient char-
acteristics and health service utilization in the entire popu-
lation of colorectal cancer patients diagnosed in Alberta in
years 2000–2005 versus the sample of 1672 patients. The
sample of patients included in the study is representative
of the population on the factors examined.
Table 2 describes the endoscopy data obtained from
the chart review. There were 1506 endoscopies identified
from the patient charts. Over half (65%) of the data were
abstracted from pathology reports, nearly 30% of the en-
doscopies were sigmoidoscopies, and the results for 93%
of the endoscopies were a cancer diagnosis.
Table 3 summarizes the total number of patients and
endoscopy procedures identified from each data source
relative to the gold standard and the number and per-
cent that were uniquely identified from each data source.
Out of 1672 patients included in the study, a total of
1937 endoscopy procedures conducted on 1443 patients
(86%) were identified by the gold standard. The com-
bined administrative data identified 1732 (89%) of the
endoscopy procedures and 1403 (84%) of the patients,
this was somewhat higher than the endoscopies (1506,
78%) and patients who had an endoscopy (1310, 78%)
identified by chart review alone. The physician billing
Table 1 Patient characteristics of cohort and sample
Characteristics Cohort (%) Sample (%)
Total Number 8310 (100) 1672 (100)
Age at diagnosis
Mean [Median] 69 [70] 69 [70]
<=65 3042 (37) 643 (38)
66-74 2172 (26) 437 (26)
>=75 3096 (37) 592 (35)
Stage at diagnosis
I-III 5500 (66) 1145 (68)
IV or Unknown 2810 (34) 527(32)
Type of 1st colorectal cancer-related visit1
Late2 event 2545 (31) 506 (30)
(Pre)Diagnostic event 5765 (69) 1166 (70)
Time from diagnosis to death (days)3
Mean [Median] 661 [453] 711 [466]
<= 1 month 491 (11) 84 (10)
1 - 3 months 472 (11) 90(10)
>= 3 months 3431(78) 710 (80)
1 Limited to healthcare visits within 1 year prior to diagnosis of colorectal cancer.
2 Late event is defined as a visit that included treatment-related events (e.g., surgery, palliative care) rather than diagnostic or pre-diagnostic events (e.g.,
radiology, symptoms). Patients who did not have any colorectal cancer-related healthcare visits are also included in this group.
3 Includes only patients who died on or before March 31, 2009.
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lar completeness to the chart review alone identifying
1566 (81%) of endoscopies conducted and 1300 (78%) of
the patients.
Similar to the results of the overall completeness of
the single data sources, the chart review identified the
most patients (40) and endoscopies (205) uniquely and
the physician billing identified the most of the individual
administrative data sources: 91 patients and 125 endos-
copies. The combined administrative data, however,
identified 133 patients (9%) and 431 endoscopies (22%)
that were not found in the chart review.Table 2 Summary of endoscopy information from the
chart review
Description N (%)






Not Cancer 55 (4)
Suspicious 45 (3)
Source of Information
Pathology Report 979 (65)
Letter or Dictation Note 527 (35)Patients identified in the hospital inpatient data tended
to be older and have higher stage than those identified
in the other data sources: 25% of patients with an endos-
copy in the inpatient data were 80 years of age or older
compared to 15-20% in the other single data sources
and 33% had stage IV disease compared to 16-19% in
the other single data sources.
Of the 1732 endoscopies identified in the combined ad-
ministrative dataset, 1289 (74%) were found in the phys-
ician billing plus at least one of the hospital datasets and
1254 (97%) of these had an exact match for the date of the
procedure (not shown in the tables), illustrating near-
perfect agreement between the physician billing and hos-
pital data with respect to dates of endoscopy procedures.
Table 4 describes the level of agreement between data
sources with respect to number of patients who had an
endoscopy procedure and number of endoscopies identi-
fied. The highest level of agreement was between the
chart review and combined administrative data with 90%
agreement on patients identified (or not) with endoscopy
and 71% agreement on endoscopies identified (or not).
Agreement between physician billing and chart review
was only slightly less at 85% for the patient level and
69% at the endoscopy level. The lowest agreement was
between the hospital inpatient and outpatient data which
was 26% at the patient level and 34% at the endoscopy
level. Most of the agreement at both the patient and en-
doscopy levels between these two data sources was due
to the “no” cells, that is, 384 of the 443 patients (87%)
Table 3 Total number of patients and endoscopies identified by different data sources
Data Source All Patients Patients with Endoscopy Patients without Endoscopy Total Number of Endoscopies
n (%) n (%)1 n (%)1 n (%)2
1672 (100)
Gold Standard 1443 (86) 229 (14) 1937 (100)
Chart Review 1310 (78) 362 (22) 1506 (78)
Unique3 40 (3) 205 (11)
Physician Billing 1300 (78) 372 (22) 1566 (81)
Unique3 24 (2) 152 (8)
Unique admin data4 91 (7) 125 (6)
Hospital Inpatient 326 (19) 1346 (81) 354 (18)
Unique3 9 (<1) 33 (2)
Unique admin data4 56 (4) 39 (2)
Hospital Outpatient 1021 (61) 651 (39) 1126 (58)
Unique3 4 (<1) 30 (2)
Unique admin data4 32 (2) 63 (3)
Combined Administrative 1403 (84) 269 (16) 1732 (89)
Unique3 133 (9) 431 (22)
1 Percent based on all patients included in the study (n=1443).
2 Percent based on total number of endoscopies identified in gold standard (n=1937).
3 Number (percentage) identified in one and only one data source.
4 Number (percentage) identified in one and only one of the administrative data sources, may also be identified from the chart review.
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copy in either data source. Agreement between the phys-
ician billing and hospital inpatient was only slightly
better at 37% for both patient and endoscopy level, how-
ever, the agreement was roughly equally split due to
consistency in identifying patients who had (283
patients) or did not have (329 patients) an endoscopy.
In order to assess the likelihood that endoscopies were
missed, even in the Gold Standard, clinical characteris-
tics and health care service utilization were compared
between patients who had an endoscopy (n=1442) to
those who did not (n=230) according to the Gold Stand-
ard. Results are shown in Table 5. Patients who did not
have a record of endoscopy were more likely to be diag-
nosed with stage IV disease (P <0.0001), had shorterTable 4 Number and percent agreement of patients and endo
Physician Billing Hospital Inpatie
n (%) n (%)
Chart Review
Patient 1422 (85) 618 (37)






Endoscopysurvival from diagnosis (P <0.0001), and were more
likely for their first colorectal-related health care visit in
the year prior to their diagnosis to be a “late” event
(P <0.0001) than those who had an endoscopy record.
“Late” events were defined as visits that involved only
services expected after cancer diagnosis has been made,
such as surgery or palliative care, and did not include
any expected pre-diagnostic services such as endoscopy,
radiology, or presentation with symptoms.
Discussion
The purpose of this study was to determine the complete-
ness and accuracy (with respect to dates) of various ad-
ministrative data sources in identifying endoscopies in the
year prior to colorectal cancer diagnosis. The findings ofscopies across data sources
nt Hospital Outpatient Combined Administrative
n (%) n (%)
1225 (73) 1499 (90)





Table 5 Patient characteristics of those who had an endoscopy prior to colorectal cancer diagnosis compared to those
who did not in the Gold Standard dataset





Total Number 229 (100) 1443 (100)
Age at diagnosis 0.24
Mean [Median] 70 [72] 68 [69]
<=65 84 (37) 559 (39)
66-74 53 (23) 384 (26)
>=75 92 (40) 500 (35)
Stage at diagnosis <.0001
I-III 110 (48) 1035 (72)
IV or Unknown 119 (52) 408 (28)
Type of 1st colorectal cancer-related visit1 <.0001
Late2 event 104 (45) 402 (28)
(Pre)Diagnostic event 125 (55) 1041 (72)
Time from diagnosis to death (days)3 <.0001
Mean [Median] 467 [200] 771 [546]
<= 1 month 41 (24) 43 (6)
1 - 3 months 20 (11) 70 (10)
>= 3 months 111 (64) 599 (84)
1 Limited to healthcare visits within 1 year prior to diagnosis of colorectal cancer.
2 Late event is defined as a visit that included treatment-related events (e.g., surgery, palliative care) rather than diagnostic or pre-diagnostic events (e.g.,
radiology, symptoms). Patients who did not have any colorectal cancer-related healthcare visits are also included in this group.
3 Includes only patients who died on or before March 31, 2009.
Li et al. BMC Health Services Research 2012, 12:358 Page 6 of 8
http://www.biomedcentral.com/1472-6963/12/358the study support the use of physician billing alone or
combined with hospital inpatient and outpatient data as
reasonable data sources for identifying patients who have
had at least one endoscopy in the year prior to colorectal
cancer diagnosis but a combination of hospital and phys-
ician billing data is recommended to identify the total
number of endoscopies received. This conclusion is
restricted to the setting in which the majority of physicians
performing endoscopy are remunerated on a fee-for-
service basis in the single-payer health care system and/or
in which salaried physicians submit claims for procedures
performed. Hospital data alone are not good sources for
this information because a significant number and per-
centage of endoscopies occur outside the hospital.
Physician billing data are created for the purpose of re-
munerating physicians who are paid on a fee-for-service
schedule. The completeness of the data is likely to be
high if specific fee code exists for a well-defined proced-
ure (such as endoscopy) and physicians have the incen-
tive to record the procedure accurately in their claim for
their fee reimbursement. Accuracy of the physician bill-
ing data, therefore, is subject to the fee code policy. The
results of studies based on physician billing data could
easily be misinterpreted if certain procedure codes are
unknowingly under or over claimed due to variances in
reimbursement for related and/or similar procedures.
Caution is, therefore, needed in the conduct andinterpretation of studies based on physician billing data;
strong understanding of the way in which physicians use
billing codes and the percentage of physicians who per-
form the procedure of interest that bill for it is needed.
Validation of the data is also critical.
One of the shortcomings to our method of validation
was the lack of independence between our gold standard
dataset and our comparison data sets. Our study did not
evaluate the accuracy of the endoscopy with respect to
type of exam (colonoscopy vs. sigmoidoscopy) or reason
for exam (screening vs. diagnosis), however, a few stud-
ies have done so. Not surprisingly, they have all found
that administrative data are not adequate for assessing
this level of specificity with respect to type or reason for
exam [9,27-29]. For instance, Schenck et al. found Medi-
care claims to be accurate for identifying endoscopies
but not for distinguishing screening from diagnostic
tests. This is at least in part due to the absence of billing
codes that are specific to screening tests but even if
implemented, the fee code would need to be comparable
to the diagnostic fee code in order to provide physicians
incentive to use it.
As mentioned, it is expected that patients with colo-
rectal cancer would have at least one endoscopy proced-
ure prior to their diagnosis as endoscopy is the most
common definitive diagnostic procedure. Fourteen per-
cent of the patients in the study, however, did not have
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the likelihood that endoscopies were missed, even in the
gold standard, we explored clinical characteristics and
other health service utilization of patients who did not
have an endoscopy procedure identified in any of the
data sources (n=230). About half of these patients pre-
sented with stage IV disease and about half had at least
one colorectal-related symptom at a healthcare visit
within one year prior to their colorectal cancer diagno-
sis. One would expect that patients who had colorectal-
related symptoms prior to diagnosis would have had an
endoscopy so it is possible that endoscopies for these
patients (n=110) were incorrectly missed. Alternatively,
it is possible that some of these patients were diagnosed
via an alternative route such as by a CT scan that identi-
fied metastatic disease or as an emergency patient that
went straight to surgery. The high percentage of patients
with stage IV disease who did not have an endoscopy
recorded makes these alternative diagnostic routes likely.
Additionally, some patients may have had an endoscopy
in another province. A minority of cancer patients
receives treatment outside the province and some may
receive some or all of their diagnostic work-up outside
the province as well. Given these possible scenarios, it is
likely that at least 100 to 125 patients (5–7.5%) of the
total patient cohort did not have an endoscopy at all or
in Alberta prior to their colorectal cancer diagnosis. The
patients who received endoscopies within Alberta as part
of the process in diagnosing colorectal cancer, therefore,
seem to have been properly identified in the gold stand-
ard created for the study combining chart review and
administrative data sources.
Conclusion
Usually the gold standard for validation of administrative
data is a disease registry database or medical records
[10,12,18,22,30,31]. We chose to combine the information
from chart review and each administrative dataset because
of recognized limitations to each data source on its own for
identifying endoscopies and potential inaccuracies of dates.
Additionally, because it is expected that all but a small mi-
nority of patients diagnosed with colorectal cancer would
have at least one endoscopy in the year prior to diagnosis
we were confident that the probability of a false positive in
any data source would be negligible. The findings of this
study with respect to completeness and accuracy of data
sources should be generalizable across Canada and in other
jurisdictions in which endoscopies are reimbursed via fee-
for-service and similar datasets exist. This is because in
Canada, the inpatient and outpatient databases are standar-
dized nationally, even though they are prepared provin-
cially, and have ongoing quality assessments made to them
nationally [32]. Furthermore, we expect the methodology
for creating a gold standard to be appropriate in similarscenarios in which the procedure is well-defined, is
expected to occur in the majority of the population, and for
which a true gold standard does not exist. In the absence of
an official registry database for endoscopy procedures,
physician billing combined with hospital data is the most
complete source of information to identify endoscopies.
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